UAB Hospital is a 1,157 bed tertiary hospital and academic health science center located in Birmingham, Alabama. It serves as the only ACS verified Level I Trauma Center in Alabama, and is the flagship property of the UAB Health System which is owned by the University of Alabama System.

There are 1,157 beds in University of Alabama Hospital.

During the past decade, University of Alabama Hospital conducted 83 clinical trials. In the 10-year time frame, 83 clinical trials started and 42 clinical trials were completed, i.e. on average, 50.6% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 21 clinical trials were completed. i.e. 43.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Alabama Hospital" #1 sponsor was "Abbott Medical Devices" with 21 trials, followed by "University of Alabama at Birmingham" with 21 trials sponsored, "Pfizer" with 6 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored and "Medtronic Cardiovascular" with 4 trials sponsored. Other sponsors include 85 different institutions and companies that sponsored additional 77 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Alabama Hospital" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 8 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Medical University of South Carolina" with 3 trials as a collaborator and "United States Department of Defense" with 3 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "University of Alabama Hospital" are "Heart Failure" (8 trials), "Coronary Artery Disease" (6 trials), "Stroke" (4 trials), "Alzheimer's Disease" (3 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "University of Alabama Hospital" in a lesser frequency.

Most popular intervention types in "University of Alabama Hospital" are "Drug" (74 trials), "Device" (46 trials), "Other" (20 trials), "Procedure" (9 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Apixaban" (3 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "Coronary PCI guided by Angiography" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Alabama Hospital" are 131 trials for "All" genders, 12 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "University of Alabama Hospital". undefined are not yet recruiting, 35 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 65 completed trials in University of Alabama Hospital, 1 suspended trials, and 27 terminated clinical trials to date.

Out of the total trials that were conducted in University of Alabama Hospital, 15 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 44 trials that are defined as “Not Applicable".

University of Alabama Hospital has several departments that took part in Clinical trials: "UAB Dermatology" - 7 trials, "University of Alabama at Birmingham, IDS Pharmacy" - 7 trials, "Hazelrig-Salter Radiation Oncology Center" - 7 trials, "University of Alabama Hematology Oncology Clinic at Medical West" - 4 trials, "Spain Rehabilitation Center" - 3 trials, "University of Alabama at Birmingham (UAB) - The Kirklin Clinic (TKC) - Multidisciplinary Comprehensive Diabetes Clinic (MCDC)" - 2 trials